Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > ProS1


Brief Information

Name:Prostate-specific antigen
Target Synonym:P-30 antigen,Semenogelase,APS,Prostate-specific antigen,PSA,Kallikrein Related Peptidase 3,Gamma-Seminoprotein,Kallikrein-3,Seminin,Kallikrein 3, (Prostate Specific Antigen),EC,KLK2A1,HK3,KLK3,EC 3.4.21,EC:
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
PR1-H52H4 Human Human ProS1 Protein, His Tag
PR1-H52H3 Human Human ProS1 Protein, His Tag
ACRO Quality

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Afala Approved Materia Medica Holding Research And Production Company Russian Federation Prostatic Neoplasms; Prostatitis Materia Medica Holding Research And Production Company 2014-01-01 Prostatic Neoplasms; Prostatitis Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Prostate cancer subunit vaccine (Progenics) Phase 1 Clinical Prostatic Neoplasms Details
P-PSMA-101 P-PSMA-101 Phase 1 Clinical Poseida Therapeutics Inc Genital Neoplasms, Male; Salivary Gland Neoplasms; Neoplasms; Carcinoma, Adenoid Cystic; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms; Carcinoma, Mucoepidermoid; Carcinoma, Acinar Cell; Urogenital Neoplasms; Prostatic Diseases Details
GEA-408 GEA-408 Phase 2 Clinical GenEros Biopharma Hangzhou Ltd Prostatic Neoplasms Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message